title: [Citrate therapy in treating urate nephrolithiasis].
abstract: Citrate therapy was tried in 483 patients with urate nephrolithiasis. A good response was obtained both in monotherapy or in combination of urates with invasive or remote treatment. The authors advocate the drug blemaren (ESPARMA, Germany) as most beneficial among citrate drugs.
authors.forename: N F
authors.initials: NF
authors.lastname: Sergienko
authors.forename: L V
authors.initials: LV
authors.lastname: Shaplygin
authors.forename: S F
authors.initials: SF
authors.lastname: Kuchits
mesh_terms: D002951:Citrates / Q000627:therapeutic use*; D006801:Humans; D007669:Kidney Calculi / Q000737:chemistry / Q000188:drug therapy*; D016896:Treatment Outcome; D014527:Uric Acid / Q000737:chemistry*
chemical_list: D002951:Citrates; D014527:Uric Acid